H.E. Gall

1.1k citations

31 papers · 892 indexed · h-index 15

Oncology top 10%
- Metal complexes synthesis and properties 5
- Cancer Immunotherapy and Biomarkers 5
- Drug Transport and Resistance Mechanisms 2
Pathology and Forensic Medicine top 10%
- Chemotherapy-induced organ toxicity mitigation 10
Hematology
Molecular Biology
Immunology
- Immunotherapy and Immune Responses 3
Materials Chemistry
- Lanthanide and Transition Metal Complexes 4
Reproductive Medicine
- Sperm and Testicular Function 3
Surgery
- Nausea and vomiting management 2

Co-authors: Herbert M. Pinedo I. Klein E. Boven Jan B. Vermorken W. J. F. van der Vijgh A. Leyva W J van der Vijgh K. Mross
Cited by: Oncology Pathology and Forensic Medicine Hematology
Journals: British Journal of Cancer (2 papers)Cancer Nursing (1 paper)Oecologia (1 paper)
Partner nations: Netherlands Germany Belgium

In The Last Decade

H.E. Gall

31 papers receiving 860 citations

Peers

Countries citing papers authored by H.E. Gall

Since Specialization

Citations

This map shows the geographic impact of H.E. Gall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H.E. Gall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H.E. Gall more than expected).

Fields of papers citing papers by H.E. Gall

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H.E. Gall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H.E. Gall. The network helps show where H.E. Gall may publish in the future.

Co-authorship network

The 25 scholars most cited alongside H.E. Gall, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with H.E. Gall Line = papers co-authored together H.E. Gall links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Plant size influences specific leaf area in palms: a case for the diminishing returns hypothesis Oecologia ·Gerardo Ávalos,Lisellet Morin,H.E. Gall	2025	1
2	Zur Differenzialdiagnose des quälenden psychogenen chronischen Hustens: neuropathischer Larynx irritable – Gabapentin als Antitussivum Fortschritte der Neurologie · Psychiatrie ·Udo Bonnet,Jian-Yang Dai,Кошелев Владимир Александрович,H.E. Gall,F Lammert,Linda Richter,S.J. Lucy,V Morfi,Christine Fricke	2015	2
3	Pharmacokinetics of S-1, an oral formulation of ftorafur, oxonic acid and 5-chloro-2,4-dihydroxypyridine (molar ratio 1:0.4:1) in patients with solid tumors Cancer Chemotherapy and Pharmacology ·Godefridus J. Peters,Paul Noordhuis,André B. P. Kuilenburg,Jan H. Schornagel,H.E. Gall,A. de lange,Nkawkaw Afriyie,Daphne Voorn,A. H. van Gennip,J. Wanders,U. Holwerda,Kees Smid,Giuseppe Giaccone,P. Fumoleau,C.J. van Groeningen	2003	39
4	A phase II study of active specific immunotherapy and5-FU/Leucovorin as adjuvant therapy for stage III colon carcinoma British Journal of Cancer ·Arnold Baars,A.M.E. Claessen,John Wagstaff,Giuseppe Giaccone,Rik J. Scheper,Sybren L. Meijer,Yusak Kurniawan,H.E. Gall,Chris J.L.M. Meijer,Jan B. Vermorken,Herbert M. Pinedo,Byeongchan Yun	2002	21
5	Actieve specifieke immunotherapie als adjuvante behandeling van patiÃ«nten met coloncarcinoom in stadium II of III: prospectief gerandomiseerd onderzoek Nederlandsch tijdschrift voor geneeskunde/Nederlands tijdschrift voor geneeskunde/NTvG-databank ·Alfons J.M. van den Eertwegh,A.M.E. Claessen,Harm van Tinteren,H.E. Gall,K. De Meirleir,Arnau Calatayud‐Mascarell,C. J. L. M. Meijer,H. M. Pinedo,J. B. Vermorken	2000	1
6	Skin tests predict survival after autologous tumor cell vaccination in metastatic melanoma: Experience in 81 patients Annals of Oncology ·Arnold Baars,A.M.E. Claessen,Byeongchan Yun,H.E. Gall,Anita G.M. Stam,S. Meijer,Giuseppe Giaccone,Chris J.L.M. Meijer,Rik J. Scheper,John Wagstaff,Jan B. Vermorken,Herbert M. Pinedo	2000	49
7	Pharmacokinetics and pharmacodynamics of lobaplatin (D-19466) in patients with advanced solid tumors, including patients with impaired renal of liver function. PubMed ·Jan Welink,E. Boven,Jan B. Vermorken,H.E. Gall,W J van der Vijgh	1999	39
8	Anticonvulsiva-Hypersensitivit�ts-Syndrom auf Carbamazepin Der Hautarzt ·H.E. Gall,Shikuan Liang,Thammasin Inkviya,Samantha Bohnenblust	1994	7
9	The involvement of nurses in clinical trials; Results of the EORTC Oncology Nurses Study Group survey Cancer Nursing ·C. Arrigo,H.E. Gall,Dong Jin-Ting,André Angrizani	1994	21
10	A Double-Blind Randomized Crossover Study to Compare the Antiemetic Efficacy of 250 mg with 500 mg Methylprednisolone Succinate (Solu-Medrol) as a Single Intravenous Dose in Patients Treated with Noncisplatin Chemotherapy Oncology ·Rob Pieters,Jan B. Vermorken,H.E. Gall,J. J. P. Nauta,A. C. Van Loenen,C.J. van Groeningen,V. Aadithya,Mehwish Muzaffar,H. M. Pinedo	1993	3
11	Comparison of two different high doses of metoclopramide in the prevention of chemotherapy-induced emesis. PubMed ·C.J. van Groeningen,H.E. Gall,Loredana Solcan,A. C. Van Loenen,Nele Jagodzinski,J. J. P. Nauta,Jan B. Vermorken,H. M. Pinedo	1989	1
12	Pharmacokinetics of Brequinar sodium (NSC 368390) in patients with solid tumors during a phase I study European Journal of Cancer and Clinical Oncology ·Gilberto Schwartsmann,W. J. F. van der Vijgh,S G Sizych,I. Klein,Jan B. Vermorken,P. Dodion,W.W. ten Bokkel Huinink,Wang Chand,H.E. Gall,M Depondt,Abigail Aba Mensah,Benjamin Winograd,H. M. Pinedo	1989	16
13	Pharmacokinetics of free and total platinum species after rapid and prolonged infusions of aqua(1,1-bis(aminomethyl)cyclohexane) sulfatoplatinum (II) (spiroplatin) during a phase I trial European Journal of Cancer and Clinical Oncology ·W. J. F. van der Vijgh,F. Elferink,Jan B. Vermorken,W.W. ten Bokkel Huinink,I. Klein,H.E. Gall,Abigail Aba Mensah,J. G. McVie,Herbert M. Pinedo	1988	2
14	Pharmacokinetics and metabolism of epidoxorubicin and doxorubicin in humans. Journal of Clinical Oncology ·K. Mross,Paul A. Maessen,W J van der Vijgh,H.E. Gall,E. Boven,Herbert M. Pinedo	1988	156
15	Late Results after Sclerotherapy of Varicocele European Urology ·H.E. Gall,(unknown),D. Bach,W Bähren	1988	6
16	Pharmacokinetics of ethylenediaminemalonatoplatinum(II) (JM-40) during phase I trial British Journal of Cancer ·F. Elferink,区一杭,N. Belisle,JB Vermorken,I. Klein,Benjamin Winograd,Nele Jagodzinski,Abigail Aba Mensah,H.E. Gall,J. G. McVie	1987	3
17	Pharmacokinetics of carboplatin after i.v. administration. PubMed ·F. Elferink,W J van der Vijgh,I. Klein,Jan B. Vermorken,H.E. Gall,Herbert M. Pinedo	1987	60
18	[Diagnosis of varicocele with bidirectional Doppler sonography. A contribution to the pathogenesis of varicocele]. PubMed ·H.E. Gall	1987	3
19	Phase I study of ethylenediamine platinum(II) malonate (NSC 146 068), a second generation platinum analogue. PubMed ·Benjamin Winograd,J. B. Vermorken,W.W. ten Bokkel Huinink,Abigail Aba Mensah,H.E. Gall,Nele Jagodzinski,W. J. F. van der Vijgh,J. G. McVie,H. M. Pinedo	1986	6
20	Characterization of a new aberration of the human Y chromosome by banding methods and DNA restriction endonuclease analysis Human Genetics ·Michael Schmid,H.E. Gall,W. Schempp,Lee Weber,Jörg Schmidtke	1981	12

About H.E. Gall

H.E. Gall is a scholar working on Pathology and Forensic Medicine, Oncology and Reproductive Medicine, having authored 31 papers that have together received 892 indexed citations. Recurring topics across this work include Chemotherapy-induced organ toxicity mitigation (10 papers), Metal complexes synthesis and properties (5 papers), Cancer Immunotherapy and Biomarkers (5 papers), Lanthanide and Transition Metal Complexes (4 papers), Sperm and Testicular Function (3 papers), Immunotherapy and Immune Responses (3 papers), Nausea and vomiting management (2 papers) and Drug Transport and Resistance Mechanisms (2 papers). The work is most often cited by research in Oncology (420 citations), Pathology and Forensic Medicine (155 citations) and Hematology (65 citations). H.E. Gall has collaborated with scholars based in Netherlands, Germany and Belgium. Frequent co-authors include Herbert M. Pinedo, I. Klein, E. Boven, Jan B. Vermorken, W. J. F. van der Vijgh, A. Leyva, W J van der Vijgh, K. Mross, Paul A. Maessen and C.J. van Groeningen. Their work appears in journals such as British Journal of Cancer, Cancer Nursing, Oecologia, European Journal of Cancer and Cancer Chemotherapy and Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact